Health Economics, Policy and Law

2006 - 2025

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 12, issue 4, 2017

Health equality, social justice and the poverty of autonomy pp. 411-433

Christopher Newdick

Innovation, informed consent, health research and the Supreme Court: Montgomery v Lanarkshire – a brave new world? pp. 435-452

Jean V. Mchale

Healthcare innovation and patent law’s ‘pharmaceutical privilege’: is there a pharmaceutical privilege? And if so, should we remove it? pp. 453-470

Graham Dutfield

Regulatory theory: commercially sustainable markets rely upon satisfying the public interest in obtaining credible goods 1 pp. 471-493

Amanda Warren-Jones

Legal and organisational innovation in the Italian pharmacy system: commercial vs public interest pp. 495-513

Alceste Santuari

Volume 12, issue 3, 2017

A place in the sun? Healthcare rights of retired UK citizens in Spain post-Brexit pp. 297-307

Joaquin Cayon-De Las Cuevas and Tamara Hervey

Democratic transitions, health institutions, and financial protection in the emerging economies: insights from Asia pp. 309-323

Eduardo J. Gómez

Contested evidence: a Dutch reimbursement decision taken to court pp. 325-344

Floortje Moes, Eddy Houwaart, Diana Delnoij and Klasien Horstman

Health plan choice in the Netherlands: restrictive health plans preferred by young and healthy individuals pp. 345-362

Romy E. Bes, Emile C. Curfs, Peter P. Groenewegen and Judith D. de Jong

The determinants of defensive medicine practices in Belgium pp. 363-386

Tom Vandersteegen, Wim Marneffe, Irina Cleemput, Dominique Vandijck and Lode Vereeck

Identifying health system value dimensions: more than health gain? pp. 387-400

Joan Costa-Font, Azusa Sato and Joan Rovira Forns

Contested evidence: a Dutch reimbursement decision taken to court – CORRIGENDUM pp. 401-401

Floortje Moes, Eddy Houwaart, Diana Delnoij and Klasien Horstman

Volume 12, issue 2, 2017

What level of domestic government health expenditure should we aspire to for universal health coverage? pp. 125-137

Di Mcintyre, Filip Meheus and John-Arne Røttingen

Raising more domestic money for health: prospects for low- and middle-income countries pp. 139-157

Riku Elovainio and David B. Evans

Fiscal space for domestic funding of health and other social services pp. 159-177

Filip Meheus and Di McIntyre

Framing the tax and health nexus: a neglected aspect of public health concern pp. 179-194

David Mccoy, Simukai Chigudu and Taavi Tillmann

Global public goods for health: weaknesses and opportunities in the global health system pp. 195-205

Suerie Moon, John-Arne Røttingen and Julio Frenk

Development assistance for health: critiques, proposals and prospects for change pp. 207-221

Suerie Moon and Oluwatosin Omole

Development assistance for health: what criteria do multi- and bilateral funders use? pp. 223-244

Trygve Ottersen, Aparna Kamath, Suerie Moon, Lene Martinsen and John-Arne Røttingen

Distributing development assistance for health: simulating the implications of 11 criteria pp. 245-263

Trygve Ottersen, Suerie Moon and John-Arne Røttingen

The challenge of middle-income countries to development assistance for health: recipients, funders, both or neither? pp. 265-284

Trygve Ottersen, Suerie Moon and John-Arne Røttingen

Towards a coherent global framework for health financing: recommendations and recent developments pp. 285-296

Trygve Ottersen, Riku Elovainio, David B. Evans, David McCoy, Di Mcintyre, Filip Meheus, Suerie Moon, Gorik Ooms and John-Arne Røttingen

Volume 12, issue 1, 2017

The regulation of competition in the National Health Service (NHS): what difference has the Health and Social Care Act 2012 made? pp. 1-19

Marie Sanderson, Pauline Allen and Dorota Osipovic

Complementary logics of target-setting: hierarchist and experimentalist governance in the Scottish National Health Service pp. 21-41

Laura Schang and Alec Morton

The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration? pp. 43-59

Natasha Azzopardi-Muscat, Peter Schroder-Bäck and Helmut Brand

The double-edged sword of corporatisation in the hospital sector: evidence from Indonesia pp. 61-80

Asri Maharani and Gindo Tampubolon

The United States confronts Ebola: suasion, executive action and fragmentation pp. 81-104

Scott L. Greer and Phillip M. Singer

Volume 11, issue 4, 2016

Is the pro-competition policy an effective solution for China’s public hospital reform? pp. 337-357

Jay Pan, Xuezheng Qin and Chee-Ruey Hsieh

Explaining medical disputes in Chinese public hospitals: the doctor–patient relationship and its implications for health policy reforms pp. 359-378

Alex Jingwei He and Jiwei Qian

How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai pp. 379-395

Wei Yang

The future of Indian Health Services for native Americans in the United States: an analysis of policy options and recommendations pp. 397-414

Tiffany Henley and Maureen Boshier

Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use pp. 415-432

Anthony Culyer

Beyond the threshold pp. 433-438

Anthony Harris

Clarifying the role of values in cost-effectiveness pp. 439-443

Michael K. Gusmano and Gregory Kaebnick

Cost-effectiveness thresholds: a comment on the commentaries pp. 445-447

Anthony Culyer

Volume 11, issue 3, 2016

Equity in health care financing in Portugal: findings from the Household Budget Survey 2010/2011 pp. 233-252

Carlota Quintal and José Lopes

Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe pp. 253-273

Olga Löblová

Out-of-pocket payments and community-wide health outcomes: an examination of influenza vaccination subsidies in Japan pp. 275-302

Yoko Ibuka and Shun-ichiro Bessho

Health reform in Finland: current proposals and unresolved challenges pp. 303-319

Richard B. Saltman and Juha Teperi

Medical savings accounts: assessing their impact on efficiency, equity and financial protection in health care pp. 321-335

Olivier J. Wouters, Jonathan Cylus, Wei Yang, Sarah Thomson and Martin McKee

Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe – CORRIGENDUM pp. 336-336

Olga Löblová

Volume 11, issue 2, 2016

Why healthcare providers merge pp. 121-140

Jeroen Postma and Anne-Fleur Roos

Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands pp. 141-159

Daniëlle M.I.D. Duijmelinck and Wynand P.M.M. van de Ven

Results of the market-oriented reform in the Netherlands: a review pp. 161-178

Hans Maarse, Patrick Jeurissen and Dirk Ruwaard

Can a medical need clause help manage the growing costs of prescription drugs in the EU? pp. 179-192

Eleanor Brooks and Robert Geyer

Influence of provider mix and regulation on primary care services supplied to US patients pp. 193-213

Michael R. Richards and Daniel Polsky

Not everything is black or white: commentary on Filc D and Cohen N, blurring the boundaries between public and private health care services as an alternative explanation for the emergence of black medicine: the Israeli case pp. 215-221

David Chinitz and Avi Israeli

If it looks like a duck, swims like a duck, and quacks like a duck, it probably is a duck: black market medicine and privatization in Israel pp. 223-225

Dani Filc and Nissim Cohen

Review Essay pp. 227-231

Paul McCrone

Volume 11, issue 1, 2016

The role of the payment vehicle in non-market valuations of a health care service: willingness-to-pay for an ambulance helicopter service pp. 1-16

Dorte Gyrd-Hansen

Making governance work in the health care sector: evidence from a ‘natural experiment’ in Italy pp. 17-38

Sabina Nuti, Federico Vola, Anna Bonini and Milena Vainieri

The determinants of efficiency in the Canadian health care system pp. 39-65

Sara Allin, Michel Grignon and Li Wang

Making Fair Choices: a symposium pp. 67-69

Albert Weale

Making fair choices on the path to universal health coverage: a précis pp. 71-77

Alex Voorhoeve, Trygve Ottersen and Ole F. Norheim

The administrator’s perspective pp. 79-83

Addis Tamire Woldemariam

Information will be the key to successful implementation pp. 85-89

Peter Littlejohns and Kalipso Chalkidou

Reasonable disagreement and the generally unacceptable: a philosophical analysis of Making Fair Choices pp. 91-96

Benedict E. Rumbold and James Wilson

The path from nowhere? pp. 97-102

Albert Weale

Response to our critics pp. 103-111

Alex Voorhoeve, Trygve Ottersen and Ole Fritjof Norheim

Democratic Governance and Health. Hospitals, Politics and Health Policy in New Zealand, by Miriam Laugesen and Robin Gauld, ISBN 978 1 877578 27 4, Dunedin: Otago University Press, 2012, 220 pp pp. 113-119

Martin Powell